ArticleJournal of nanobiotechnology2026

An oral nanocombinatorial agent exhibits pleiotropic improvement in diabetic nephropathy via modulation of the SCAP/SREBPs pathway.

Yu Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.